序号 |
标题 |
次数 |
作者 |
发布时间 |
82621 |
DOTA-pNO2Phe-c[DCys-Tyr-DTrp-Lys-Thr-Cys]-DTyr-NH2 |
125 |
kx |
2024-11-29 |
82622 |
MeTz-PEG7-NOTA 甲基四嗪-聚乙二醇-大环化合物 Me-Tetrazine-PEG7-NOTA |
74 |
zyl |
2024-11-29 |
82623 |
DOTAGA-四叔丁酯,306776-79-4,DOTAGA-(COOt-Bu)4 |
167 |
zcy |
2024-11-29 |
82624 |
金刚烷改性氰酸酯树脂 AD-CE |
185 |
h |
2024-11-29 |
82625 |
DOTA-Tyr-Lys-DOTA ;DOTA-酪氨酸-赖氨酸-DOTA |
70 |
wyh |
2024-11-29 |
82626 |
HA-DOTA tate , DOTA-3-碘-Tyr 3-奥曲肽 , HA-DOTATATE |
100 |
kx |
2024-11-29 |
82627 |
NOTA-E(cRGDfK)2 , NOTA修饰多肽 |
104 |
wyh |
2024-11-29 |
82628 |
叠氮-NOTA cas:2125661-92-7 NOTA-Azide/N3 |
99 |
zyl |
2024-11-29 |
82629 |
金刚烷改性壳聚糖 AD-CS |
139 |
h |
2024-11-29 |
82630 |
DOTA-c(RGDfK) , 螯合物前体多肽 |
136 |
wyh |
2024-11-29 |
82631 |
DOTA-Lys-PEG(4)[D-Phe(6) |
91 |
kx |
2024-11-29 |
82632 |
葫芦[7]脲包裹盐酸金刚烷胺 CB[7]-AD |
122 |
h |
2024-11-29 |
82633 |
L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide, 2,2,2-trifluoroacetate (1:) 定制 |
81 |
zcy |
2024-11-29 |
82634 |
N-金刚烷基-N-芳杂基二酰肼类化合物 |
177 |
h |
2024-11-29 |
82635 |
DOTA-奥曲肽 ,DOTA-Octreotide |
109 |
wyh |
2024-11-29 |
82636 |
CAS:147597-66-8 p-SCN-Bn-NOTA |
86 |
zyl |
2024-11-29 |
82637 |
金刚烷衍生物 |
169 |
h |
2024-11-29 |
82638 |
NOTA-EXENDIN-4 |
88 |
zyl |
2024-11-29 |
82639 |
DOTA-PDAP-PNA-肽探针 |
92 |
kx |
2024-11-29 |
82640 |
β-环糊精磁性棕榈纤维生物炭 β-CD@PFMBC |
148 |
h |
2024-11-29 |
82641 |
DOTA-octreotide ,DOTA-奥曲肽 ,大环配体多肽 |
124 |
wyh |
2024-11-29 |
82642 |
β-环糊精包埋β-胡萝卜素 β-C-β-CD |
155 |
h |
2024-11-29 |
82643 |
DOTA-8-氨基辛酸 , DOTA-8-amino octanoic acid |
94 |
kx |
2024-11-29 |
82644 |
NOTA-Me-Tetrazine NOTA-甲基四嗪 |
90 |
zyl |
2024-11-29 |
82645 |
环糊精类手性离子液体(β-CD-IL) |
232 |
h |
2024-11-29 |
82646 |
DOTA-[D-Glu(1-6) , 谷氨酸残基的结构化接头DOTA |
130 |
kx |
2024-11-29 |
82647 |
DOTA-多肽分子探针 ,RGD多肽偶联的酞菁硅光敏剂 |
106 |
wyh |
2024-11-29 |
82648 |
金属离子配合物NO2A-Butyne,2089035-56-1 |
166 |
zyl |
2024-11-29 |
82649 |
DOTA-2P-[FAPI]2, FAP抑制剂(FAPI)二聚体 |
198 |
kx |
2024-11-29 |
82650 |
1293368-74-7;DOTA标记的多肽 |
107 |
wyh |
2024-11-29 |
82651 |
透明质酸-羟丙基-β-环糊精主动靶向接枝物(HA-CDs,分子量为7,63,102 kDa) |
145 |
h |
2024-11-29 |
82652 |
载脂蛋白E衍生肽-NOTA |
127 |
zyl |
2024-11-29 |
82653 |
DOTA-HYNIC-Lys(Nal)-Urea-Glu , DOTA HYNIC-Lys(Nal)-尿素-谷氨酸 |
93 |
kx |
2024-11-29 |
82654 |
DOTA标记多肽,DOTA-cyclo(RGDyK) |
112 |
wyh |
2024-11-29 |
82655 |
NOTA-琥珀酰亚胺酯,NOTA-NHS ester,1338231-09-6 |
82 |
zyl |
2024-11-29 |
82656 |
DOTA修饰的药物分子 |
162 |
wyh |
2024-11-29 |
82657 |
聚乙烯亚胺PEI600-γ-羟丙基环糊精(γ-hy-PC) |
161 |
h |
2024-11-29 |
82658 |
官能团功能化大环配体DOTA的功能化应用 |
100 |
wyh |
2024-11-29 |
82659 |
β-环糊精聚合物/二氧化钛有机-无机杂化材料(P(CD-co-AA)/TiO2) |
162 |
h |
2024-11-29 |
82660 |
蛋白配体偶联DOTA螯合剂 |
142 |
wyh |
2024-11-29 |
82661 |
PSMA-BCH |
93 |
zyl |
2024-11-29 |
82662 |
NOTA衍生物修饰生物小分子 |
145 |
wyh |
2024-11-29 |
82663 |
单(6-巯基-6-去氧)-β-环糊精手性固定相(CSP1) |
153 |
h |
2024-11-29 |
82664 |
二硫键键接Ce6的α-环糊精 α-CD-s-s-Ce6 |
118 |
h |
2024-11-29 |
82665 |
Maleimido-mono-amide-NOTA 大环配合物 |
87 |
zyl |
2024-11-29 |